Phoenix, Arizona-based Kemeta LLC, a firm developing palm-sized breath sensors, said Tuesday that it has received an investment from Dow Chemical. Kemeta said that Dow has taken a minority stake in the company. Kemeta is developing devices for detection and monitoring of an individual's fat burn rate, based on technology developed by Dow. Kemeta acquired the technology from RoseStreet Labs LLC in April. Amount of the investment was not disclosed.